Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials
Published Online: 2017-03-13
Journal: Breast Cancer Research and Treatment•Publisher: Springer Science and Business Media LLC
Authors: A. Frassoldati•A. Goubar•A. Michelotti•D. Generali•F. Piacentini•F. Puglisi•G. Banna•G. Bisagni•G. Ficarra•G. Griguolo•K. Cagossi•L. Cavanna•M. V. Dieci•Pierfranco Conte•R. Berardi•V. Guarneri
